Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3360752 | International Journal of Antimicrobial Agents | 2007 | 4 Pages |
Abstract
During the period January 2004 to April 2007, nine cases of breakthrough invasive aspergillosis occurred among 156 allogeneic haematopoietic stem cell transplant recipients receiving caspofungin therapy, mainly for empirical treatment of persisting fever. Voriconazole salvage therapy induced two complete responses. However, seven patients ultimately died a median of 5 weeks after diagnosis, including five patients with aspergillosis. This high incidence of breakthrough invasive aspergillosis in this patient population receiving caspofungin therapy warrants further investigation.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Adrienne Madureira, Anne Bergeron, Claire Lacroix, Marie Robin, Vanderson Rocha, Régis Peffault de Latour, Christèle Ferry, Agnès Devergie, Jordane Lapalu, Eliane Gluckman, Gérard Socié, Mahmoud Ghannoum, Patricia Ribaud,